Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    tovaxin
Show Display Options
Rank Status Study
1 Terminated
Has Results
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Clinically Isolated Syndrome
Intervention: Biological: Tovaxin
2 Completed Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Biological: Tovaxin Autologous T cell vaccine;   Biological: Placebo
3 Completed Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis, Secondary Progressive
Intervention: Biological: Tovaxin Autologous T Cell Vaccine

Study has passed its completion date and status has not been verified in more than two years.